Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2017 Filed Feb 10, 2017 23:02 UTC |
REX JOHN FEVP Chief Financial Officer
|
Tax withholdingCommon Stock | 481 | $160.44 | $77,171.64 |
DisclosureSEC source: 0001209191-17-009703 · doc4.xml · nonDerivative · entry 2 REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,566.35 F2 · balance_after: Amount does not include Performance Share Awards granted to the executive officer on February 8, 2017, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Share Awards is 15,595. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 23:03 UTC |
SHORT MARIANNE DEVP & Chief Legal Officer
|
Tax withholdingCommon Stock | 855 | $160.44 | $137,176.20 |
DisclosureSEC source: 0001209191-17-009705 · doc4.xml · nonDerivative · entry 4 SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,900.346 F4 · balance_after: Amount does not include Performance Share Awards granted to the executive officer on February 8, 2017, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Shares is 11,291. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 23:03 UTC |
WICHMANN DAVID SPresident
|
Tax withholdingCommon Stock | 1,820 | $160.44 | $292,000.80 |
DisclosureSEC source: 0001209191-17-009706 · doc4.xml · nonDerivative · entry 4 WICHMANN DAVID S · CIK 0001268489 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675,713.822 F4 · balance_after: Amount does not include Performance Share Awards granted to the executive officer on February 8, 2017, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Shares is 22,816. Read SEC document |
| February 09, 2017 Filed Feb 10, 2017 23:04 UTC |
WILSON D ELLENEVP Human Capital
|
Tax withholdingCommon Stock | 464 | $160.44 | $74,444.16 |
DisclosureSEC source: 0001209191-17-009707 · doc4.xml · nonDerivative · entry 2 WILSON D ELLEN · CIK 0001633390 · EVP Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,433.129 F2 · balance_after: Amount does not include Performance Share Awards granted to the executive officer on February 8, 2017, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Shares is 9,357. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:01 UTC |
Bueno Edson de GodoyDirector
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 139,395 | $0.00 Strike: $160.31 | $0.00 |
DisclosureSEC source: 0001209191-17-009700 · doc4.xml · derivative · entry 2 Bueno Edson de Godoy · CIK 0001561409 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,395 Underlying: Common Stock · 139,395 shares Expires 2027-02-08 F2 · derivative.exercise_date: The stock options will vest at a rate of 25% annually on February 8 from the years 2018 through 2021. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:01 UTC |
HEMSLEY STEPHEN JDirector · Chief Exec Officer
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 96,706 | $0.00 Strike: $160.31 | $0.00 |
DisclosureSEC source: 0001209191-17-009701 · doc4.xml · derivative · entry 9 HEMSLEY STEPHEN J · CIK 0001180162 · Director · Chief Exec Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,706 Underlying: Common Stock · 96,706 shares Expires 2027-02-08 F5 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 8 from the years 2018 through 2021. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:01 UTC |
HEMSLEY STEPHEN JDirector · Chief Exec Officer
|
Tax withholdingCommon Stock | 35,510 | $160.31 | $5,692,608.10 |
DisclosureSEC source: 0001209191-17-009701 · doc4.xml · nonDerivative · entry 3 HEMSLEY STEPHEN J · CIK 0001180162 · Director · Chief Exec Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,807,348.65 F3 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2014-2016. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:01 UTC |
HEMSLEY STEPHEN JDirector · Chief Exec Officer
|
GrantCommon Stock | 73,677 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-009701 · doc4.xml · nonDerivative · entry 2 HEMSLEY STEPHEN J · CIK 0001180162 · Director · Chief Exec Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,842,858.65 F2 · shares: Represents the settlement of Performance Share Awards for the performance period 2014-2016. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:01 UTC |
HEMSLEY STEPHEN JDirector · Chief Exec Officer
|
GrantCommon Stock | 17,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-009701 · doc4.xml · nonDerivative · entry 1 HEMSLEY STEPHEN J · CIK 0001180162 · Director · Chief Exec Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,769,181.65 F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 8 from the years 2018 through 2021. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:02 UTC |
RENFRO LARRY CVice Chmn, UHG and CEO, Optum
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 63,730 | $0.00 Strike: $160.31 | $0.00 |
DisclosureSEC source: 0001209191-17-009702 · doc4.xml · derivative · entry 5 RENFRO LARRY C · CIK 0001235046 · Vice Chmn, UHG and CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,730 Underlying: Common Stock · 63,730 shares Expires 2027-02-08 F5 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 8 from the years 2018 through 2021. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:02 UTC |
RENFRO LARRY CVice Chmn, UHG and CEO, Optum
|
Tax withholdingCommon Stock | 20,615 | $160.31 | $3,304,790.65 |
DisclosureSEC source: 0001209191-17-009702 · doc4.xml · nonDerivative · entry 3 RENFRO LARRY C · CIK 0001235046 · Vice Chmn, UHG and CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,378.719 F3 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2014-2016. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:02 UTC |
RENFRO LARRY CVice Chmn, UHG and CEO, Optum
|
GrantCommon Stock | 44,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-009702 · doc4.xml · nonDerivative · entry 2 RENFRO LARRY C · CIK 0001235046 · Vice Chmn, UHG and CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,993.719 F2 · shares: Represents the settlement of Performance Share Awards for the performance period 2014-2016. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:02 UTC |
RENFRO LARRY CVice Chmn, UHG and CEO, Optum
|
GrantCommon Stock | 11,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-009702 · doc4.xml · nonDerivative · entry 1 RENFRO LARRY C · CIK 0001235046 · Vice Chmn, UHG and CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,786.719 F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 8 from the years 2018 through 2021. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:02 UTC |
ROOS THOMAS EChief Accounting Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 26,137 | $0.00 Strike: $160.31 | $0.00 |
DisclosureSEC source: 0001209191-17-009704 · doc4.xml · derivative · entry 3 ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,137 Underlying: Common Stock · 26,137 shares Expires 2027-02-08 F2 · derivative.exercise_date: The non-qualified stock options vest at a rate of 25% annually on February 8 from the years 2018 through 2021. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:02 UTC |
ROOS THOMAS EChief Accounting Officer
|
GrantCommon Stock | 4,679 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-009704 · doc4.xml · nonDerivative · entry 1 ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,840.096 F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 8 from the years 2018 through 2021. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:02 UTC |
REX JOHN FEVP Chief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 43,561 | $0.00 Strike: $160.31 | $0.00 |
DisclosureSEC source: 0001209191-17-009703 · doc4.xml · derivative · entry 3 REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,561 Underlying: Common Stock · 43,561 shares Expires 2027-02-08 F3 · derivative.exercise_date: The non-qualified stock options vest at a rate of 25% annually on February 8 from the years 2018 through 2021. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:02 UTC |
REX JOHN FEVP Chief Financial Officer
|
GrantCommon Stock | 7,798 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-009703 · doc4.xml · nonDerivative · entry 1 REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,047.35 F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 8 from the years 2018 through 2021. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:03 UTC |
SHORT MARIANNE DEVP & Chief Legal Officer
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 31,539 | $0.00 Strike: $160.31 | $0.00 |
DisclosureSEC source: 0001209191-17-009705 · doc4.xml · derivative · entry 5 SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,539 Underlying: Common Stock · 31,539 shares Expires 2027-02-08 F5 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 8 from the years 2018 through 2021. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:03 UTC |
SHORT MARIANNE DEVP & Chief Legal Officer
|
Tax withholdingCommon Stock | 14,206 | $160.31 | $2,277,363.86 |
DisclosureSEC source: 0001209191-17-009705 · doc4.xml · nonDerivative · entry 3 SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,755.346 F3 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2014-2016. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:03 UTC |
SHORT MARIANNE DEVP & Chief Legal Officer
|
GrantCommon Stock | 29,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-009705 · doc4.xml · nonDerivative · entry 2 SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,961.346 F2 · shares: Represents the settlement of Performance Share Awards for the performance period 2014-2016. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:03 UTC |
SHORT MARIANNE DEVP & Chief Legal Officer
|
GrantCommon Stock | 5,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-009705 · doc4.xml · nonDerivative · entry 1 SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,489.346 F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 8 from the years 2018 through 2021. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:03 UTC |
WICHMANN DAVID SPresident
|
GrantNon-Qualified Stock Options (right to buy · Derivative | 63,730 | $0.00 Strike: $160.31 | $0.00 |
DisclosureSEC source: 0001209191-17-009706 · doc4.xml · derivative · entry 6 WICHMANN DAVID S · CIK 0001268489 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,730 Underlying: Common Stock · 63,730 shares Expires 2027-02-08 F5 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 8 from the years 2018 through 2021. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:03 UTC |
WICHMANN DAVID SPresident
|
Tax withholdingCommon Stock | 21,162 | $160.31 | $3,392,480.22 |
DisclosureSEC source: 0001209191-17-009706 · doc4.xml · nonDerivative · entry 3 WICHMANN DAVID S · CIK 0001268489 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 677,533.822 F3 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2014-2016. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:03 UTC |
WICHMANN DAVID SPresident
|
GrantCommon Stock | 44,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-009706 · doc4.xml · nonDerivative · entry 2 WICHMANN DAVID S · CIK 0001268489 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 698,695.822 F2 · shares: Represents the settlement of Performance Share Awards for the performance period 2014-2016. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:03 UTC |
WICHMANN DAVID SPresident
|
GrantCommon Stock | 11,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-009706 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 654,488.822 F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 8 from the years 2018 through 2021. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 23:04 UTC |
WILSON D ELLENEVP Human Capital
|
GrantCommon Stock | 4,679 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-009707 · doc4.xml · nonDerivative · entry 1 WILSON D ELLEN · CIK 0001633390 · EVP Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,897.129 F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 8 from the years 2018 through 2021. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 21:23 UTC |
HEMSLEY STEPHEN JDirector · Chief Exec Officer
|
Tax withholdingCommon Stock | 3,087 | $160.51 | $495,494.37 |
DisclosureSEC source: 0001209191-17-008674 · doc4.xml · nonDerivative · entry 1 HEMSLEY STEPHEN J · CIK 0001180162 · Director · Chief Exec Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,751,870.65 Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 21:23 UTC |
RENFRO LARRY CVice Chmn, UHG and CEO, Optum
|
Tax withholdingCommon Stock | 1,503 | $160.51 | $241,246.53 |
DisclosureSEC source: 0001209191-17-008676 · doc4.xml · nonDerivative · entry 1 RENFRO LARRY C · CIK 0001235046 · Vice Chmn, UHG and CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,378.719 Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 21:24 UTC |
REX JOHN FEVP Chief Financial Officer
|
Tax withholdingCommon Stock | 1,579 | $160.51 | $253,445.29 |
DisclosureSEC source: 0001209191-17-008677 · doc4.xml · nonDerivative · entry 1 REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,249.35 Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 21:24 UTC |
SHORT MARIANNE DEVP & Chief Legal Officer
|
Tax withholdingCommon Stock | 3,587 | $160.51 | $575,749.37 |
DisclosureSEC source: 0001209191-17-008678 · doc4.xml · nonDerivative · entry 1 SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,843.346 Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 21:25 UTC |
WICHMANN DAVID SPresident
|
Tax withholdingCommon Stock | 1,766 | $160.51 | $283,460.66 |
DisclosureSEC source: 0001209191-17-008679 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643,080.822 Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 21:25 UTC |
WILSON D ELLENEVP Human Capital
|
Tax withholdingCommon Stock | 1,190 | $160.51 | $191,006.90 |
DisclosureSEC source: 0001209191-17-008681 · doc4.xml · nonDerivative · entry 1 WILSON D ELLEN · CIK 0001633390 · EVP Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,218.129 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 22:28 UTC |
BURKE RICHARD TDirector
|
SaleCommon Stock | 10,000 | $161.68 | $1,616,750.00 |
DisclosureSEC source: 0001209191-17-007205 · doc4.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,921,191 F1 · price: This transaction was executed in multiple trades ranging from $161.57 to $161.77 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected. Read SEC document |
| January 23, 2017 Filed Jan 25, 2017 21:17 UTC |
BURKE RICHARD TDirector
|
Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 890 | $0.00 Strike: $52.21 | $0.00 |
DisclosureSEC source: 0001209191-17-005508 · doc4.xml · derivative · entry 3 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 890 shares Expires 2017-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2017 Filed Jan 25, 2017 21:17 UTC |
BURKE RICHARD TDirector
|
Exercise / conversionCommon Stock | 890 | $52.21 | $46,466.90 |
DisclosureSEC source: 0001209191-17-005508 · doc4.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,931,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:32 UTC |
BALLARD WILLIAM C JRDirector
|
GrantCommon Stock | 304 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002108 · doc4.xml · nonDerivative · entry 1 BALLARD WILLIAM C JR · CIK 0001024398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,424 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:33 UTC |
BURKE RICHARD TDirector
|
GrantCommon Stock | 304 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002112 · doc4.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,930,334 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:33 UTC |
DARRETTA ROBERT JDirector
|
GrantCommon Stock | 558 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002115 · doc4.xml · nonDerivative · entry 1 DARRETTA ROBERT J · CIK 0001188999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,581 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:34 UTC |
HOOPER MICHELE JDirector
|
GrantCommon Stock | 304 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002117 · doc4.xml · nonDerivative · entry 1 HOOPER MICHELE J · CIK 0001201723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,974 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:34 UTC |
LAWSON RODGER ADirector
|
GrantCommon Stock | 304 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002120 · doc4.xml · nonDerivative · entry 1 LAWSON RODGER A · CIK 0001187442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,575 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:41 UTC |
RENWICK GLENN MDirector
|
GrantCommon Stock | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002134 · doc4.xml · nonDerivative · entry 1 RENWICK GLENN M · CIK 0001198119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,398 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:41 UTC |
Shine Kenneth IrwinDirector
|
GrantCommon Stock | 304 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002138 · doc4.xml · nonDerivative · entry 1 Shine Kenneth Irwin · CIK 0001455025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,028 F1 · shares: Represents shares of common stock that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:42 UTC |
WILENSKY GAIL RDirector
|
GrantCommon Stock | 304 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002139 · doc4.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,434 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. Read SEC document |
| January 03, 2017 Filed Jan 9, 2017 22:33 UTC Amendment |
BALLARD WILLIAM C JRDirector
|
GrantCommon Stock | 271 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003000 · doc4a.xml · nonDerivative · entry 1 BALLARD WILLIAM C JR · CIK 0001024398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,391 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. F2 · shares: In the reporting person's original Form 4 filing, the number of shares in the "Securities Acquired or Disposed of" and "Amount of Securities Beneficially Owned Following Reported Transactions" columns were incorrectly reported. F2 · balance_after: In the reporting person's original Form 4 filing, the number of shares in the "Securities Acquired or Disposed of" and "Amount of Securities Beneficially Owned Following Reported Transactions" columns were incorrectly reported. Read SEC document |
| January 03, 2017 Filed Jan 9, 2017 22:33 UTC Amendment |
BURKE RICHARD TDirector
|
GrantCommon Stock | 271 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003001 · doc4a.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,930,301 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. F2 · shares: In the reporting person's original Form 4 filing, the number of shares in the "Securities Acquired or Disposed of" and "Amount of Securities Beneficially Owned Following Reported Transactions" columns were incorrectly reported. F2 · balance_after: In the reporting person's original Form 4 filing, the number of shares in the "Securities Acquired or Disposed of" and "Amount of Securities Beneficially Owned Following Reported Transactions" columns were incorrectly reported. Read SEC document |
| January 03, 2017 Filed Jan 9, 2017 22:34 UTC Amendment |
DARRETTA ROBERT JDirector
|
GrantCommon Stock | 465 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003003 · doc4a.xml · nonDerivative · entry 1 DARRETTA ROBERT J · CIK 0001188999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,488 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. F2 · shares: In the reporting person's original Form 4 filing, the number of shares in the "Securities Acquired or Disposed of" and "Amount of Securities Beneficially Owned Following Reported Transactions" columns were incorrectly reported. F2 · balance_after: In the reporting person's original Form 4 filing, the number of shares in the "Securities Acquired or Disposed of" and "Amount of Securities Beneficially Owned Following Reported Transactions" columns were incorrectly reported. Read SEC document |
| January 03, 2017 Filed Jan 9, 2017 22:34 UTC Amendment |
HOOPER MICHELE JDirector
|
GrantCommon Stock | 271 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003004 · doc4a.xml · nonDerivative · entry 1 HOOPER MICHELE J · CIK 0001201723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,941 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. F2 · shares: In the reporting person's original Form 4 filing, the number of shares in the "Securities Acquired or Disposed of" and "Amount of Securities Beneficially Owned Following Reported Transactions" columns were incorrectly reported. F2 · balance_after: In the reporting person's original Form 4 filing, the number of shares in the "Securities Acquired or Disposed of" and "Amount of Securities Beneficially Owned Following Reported Transactions" columns were incorrectly reported. Read SEC document |
| January 03, 2017 Filed Jan 9, 2017 22:35 UTC Amendment |
LAWSON RODGER ADirector
|
GrantCommon Stock | 271 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003005 · doc4a.xml · nonDerivative · entry 1 LAWSON RODGER A · CIK 0001187442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,542 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. F2 · shares: In the reporting person's original Form 4 filing, the number of shares in the "Securities Acquired or Disposed of" and "Amount of Securities Beneficially Owned Following Reported Transactions" columns were incorrectly reported. F2 · balance_after: In the reporting person's original Form 4 filing, the number of shares in the "Securities Acquired or Disposed of" and "Amount of Securities Beneficially Owned Following Reported Transactions" columns were incorrectly reported. Read SEC document |
| January 03, 2017 Filed Jan 9, 2017 22:35 UTC Amendment |
RENWICK GLENN MDirector
|
GrantCommon Stock | 504 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003006 · doc4a.xml · nonDerivative · entry 1 RENWICK GLENN M · CIK 0001198119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,294 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. F2 · shares: In the reporting person's original Form 4 filing, the number of shares in the "Securities Acquired or Disposed of" and "Amount of Securities Beneficially Owned Following Reported Transactions" columns were incorrectly reported. F2 · balance_after: In the reporting person's original Form 4 filing, the number of shares in the "Securities Acquired or Disposed of" and "Amount of Securities Beneficially Owned Following Reported Transactions" columns were incorrectly reported. Read SEC document |
| January 03, 2017 Filed Jan 9, 2017 22:36 UTC Amendment |
WILENSKY GAIL RDirector
|
GrantCommon Stock | 271 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003009 · doc4a.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,401 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. F2 · shares: In the reporting person's original Form 4 filing, the number of shares in the "Securities Acquired or Disposed of" and "Amount of Securities Beneficially Owned Following Reported Transactions" columns were incorrectly reported. F2 · balance_after: In the reporting person's original Form 4 filing, the number of shares in the "Securities Acquired or Disposed of" and "Amount of Securities Beneficially Owned Following Reported Transactions" columns were incorrectly reported. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.